With US measles deaths on the rise, local officials are stepping in where RFK Jr won’t

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-17T12:15:17.991Z • Permanent link

Dr. Ashish Jha, the Director of the Centers for Disease Control and Prevention (CDC), has been under intense scrutiny for his handling of the recent measles outbreak in the United States. As the country's top public health official, Jha's decisions have far-reaching consequences for the nation's health and well-being. On September 1, the CDC reported a total of 1,282 measles cases in the country, with 32% of those cases occurring in California alone. The CDC's vaccine uptake rate has also been declining, with only 93.5% of children receiving the recommended two doses of MMR vaccine by their second birthday.

The CDC's stance on vaccination has been a contentious issue, with some arguing that it is too restrictive and others claiming that it is not doing enough to address the growing measles epidemic. RFK Jr, a prominent anti-vaxxer, has been a vocal critic of the CDC's policies, claiming that they are too focused on vaccination and not enough on addressing the underlying causes of the outbreak. However, the CDC has maintained that its stance is based on scientific evidence and that vaccination is the most effective way to prevent the spread of measles.

The measles outbreak has also had significant economic implications, with many businesses and organizations suffering losses due to the spread of the disease. The California Department of Public Health has estimated that the outbreak has cost the state's economy over $50 million in lost productivity and revenue. The CDC has also reported that the outbreak has led to an increase in hospitalizations and healthcare costs, with the average cost of treating a patient with measles being around $50,000.

The recent measles outbreak has significant implications for the healthcare industry, particularly in terms of vaccine uptake and public health policy. The CDC's stance on vaccination has been a major point of contention, with some arguing that it is too restrictive and others claiming that it is not doing enough to address the growing measles epidemic. Companies such as Merck and GlaxoSmithKline have been working closely with the CDC to develop and distribute vaccines, but their efforts have been hindered by the controversy surrounding the CDC's policies.

The measles outbreak has also had significant implications for research communities, particularly in terms of understanding the causes of the outbreak and developing effective prevention strategies. Researchers at the CDC and other institutions have been working tirelessly to study the outbreak and identify the root causes, but their efforts have been hindered by the lack of data and funding. The CDC has also been criticized for its slow response to the outbreak, with some arguing that it could have been prevented with more timely and effective action.

The recent measles outbreak is part of a larger pattern of controversy surrounding public health policy and vaccine uptake. In recent years, there has been a growing trend of anti-vaxxer sentiment, with some arguing that vaccines are not safe or effective. This sentiment has been fueled in part by misinformation and disinformation, particularly on social media. The CDC has been working to address this issue, but it remains a significant challenge.